SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-016465
Filing Date
2023-05-08
Accepted
2023-05-08 16:44:29
Documents
14
Period of Report
2023-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20230508.htm   iXBRL 8-K 34885
2 EX-99.1 xncr-20230508xexx991.htm EX-99.1 73874
6 xencor.jpg GRAPHIC 8036
  Complete submission text file 0001628280-23-016465.txt   264909

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20230508.xsd EX-101.SCH 1896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20230508_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20230508_pre.xml EX-101.PRE 12504
8 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20230508_htm.xml XML 11034
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 23898415
SIC: 2834 Pharmaceutical Preparations